Table 5.

Distribution of conditions most frequently represented in the survey, ordered by condition group then primary condition (N=6264).^a IQR: interquartile range.

Patient-reported primary condition	Condition group	n (%)	Mean (SD)	Median (IQR)
Diabetes type 2	Cardiovascular and metabolic diseases	174 (2.78)	6.3 (3.9)	7 (3-9)
Fibromyalgia	Fibromyalgia (other)	668 (10.66)	6.5 (4.0)	7 (3-10)
Crohn’s disease	Inflammation and autoimmunity	49 (0.78)	5.0 (4.2)	5 (1-8)
Rheumatoid arthritis	Inflammation and autoimmunity	128 (2.04)	6.4 (4.1)	7 (3-9)
Systemic lupus erythematosus	Inflammation and autoimmunity	271 (4.33)	6.0 (4.0)	6 (2-9)
Bipolar disorder	Mental and behavioral health	245 (3.91)	6.1 (4.1)	7 (2-10)
Bipolar I disorder	Mental and behavioral health	96 (1.53)	6.9 (4.5)	7 (3-10)
Bipolar II disorder	Mental and behavioral health	130 (2.08)	6.2 (4.0)	7 (3-10)
Complex post-posttraumatic stress disorder	Mental and behavioral health	54 (0.86)	6.5 (4.4)	7 (3-10)
Major depressive disorder	Mental and behavioral health	308 (4.92)	5.7 (3.9)	6 (2-8)
Posttraumatic stress disorder	Mental and behavioral health	232 (3.70)	6.4 (4.1)	7 (3-9)
Traumatic brain injury	Mental and behavioral health	122 (1.95)	6.3 (4.3)	7 (3-10)
Myalgic encephalomyelitis/chronic fatigue syndrome	Myalgic encephalomyelitis/chronic fatigue syndrome (other)	62 (0.99)	5.1 (4.0)	5 (1-8)
Amyotrophic lateral sclerosis	Neurologic	281 (4.49)	5.8 (3.6)	6 (3-9)
Epilepsy	Neurologic	109 (1.74)	7.2 (4.5)	8 (4-11)
Multiple sclerosis	Neurologic	1005 (16.04)	6.5 (3.9)	7 (3-10)
Parkinson’s disease	Neurologic	468 (7.47)	6.2 (4.1)	7 (3-9)
Lung cancer	Oncology	98 (1.56)	5.8 (4.0)	6 (3-9)
Multiple myeloma	Oncology	93 (1.48)	4.9 (3.9)	5 (1-8)
Idiopathic pulmonary fibrosis	Respiratory	150 (2.39)	6.2 (3.8)	6 (3-9)

^aPrimary condition not reported and/or profile data unavailable for n=1170 patients.